Form 4 Tracker
Jazz Pharmaceuticals plc
JAZZ

72 insider filings · Latest: Oct 6, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 22, 2026May 27 10:13 PMRick E WinninghamDirector
Sale
2,741$241.57$662.1K9,567(D)

View →

May 22, 2026May 27 10:07 PMHeather Ann McsharryDirector
Sale
2,000$241.00$482.0K18,449(D)

View →

May 22, 2026May 22 8:27 PMHEATHER MCSHARRY
Proposed Sale
2,000$241.00$482.0K—

View →

May 22, 2026May 22 8:13 PMRICK WINNINGHAM
Proposed Sale
2,741$241.57$662.1K—

View →

May 1, 2026May 5 8:27 PMBruce C CozaddDirector
Sale
6,000$203.33$1.2M378,682(D)

View →

May 1, 2026May 1 7:44 PMBruce C Cozadd
Proposed Sale
6,000$203.33$1.2M—

View →

Apr 1, 2026Apr 3 9:09 PMBruce C CozaddDirector
Sale
6,000$190.50$1.1M384,682(D)

View →

Apr 1, 2026Apr 1 8:03 PMBruce C Cozadd
Proposed Sale
6,000$190.50$1.1M—

View →

Mar 9, 2026Mar 9 9:15 PMPatricia CarrSVP, Chief Accounting Officer
Sale
1,287$182.94$235.4K6,512(D)

View →

Mar 9, 2026Mar 9 8:26 PMPATRICIA CARR
Proposed Sale
1,287$182.94$235.4K—

View →

Mar 5, 2026Mar 5 7:48 PMCarr Patricia
Proposed Sale
2,723$188.69$513.8K—

View →

Feb 26, 2026Mar 5 6:58 PMHenderson Mary Elizabeth
Proposed Sale
2,643$188.69$498.7K—

View →

Mar 3, 2026Mar 4 9:24 PMBruce C CozaddDirector
Sale
6,000$186.44$1.1M405,796(D)

View →

Mar 3, 2026Mar 3 7:35 PMBruce C Cozadd
Proposed Sale
6,000$186.44$1.1M—

View →

Feb 27, 2026Mar 2 10:36 PMNorbert G RiedelDirector
Sale
3,415$192.00$655.7K7,024(D)

View →

Feb 27, 2026Mar 2 10:14 PMPatricia CarrSVP, Chief Accounting Officer
Sale
1,117$190.91$213.2K9,235(D)

View →

Feb 26, 2026Mar 2 10:14 PMPatricia CarrSVP, Chief Accounting Officer
Sale
1,253$194.11$243.2K10,352(D)

View →

Feb 26, 2026Mar 2 10:06 PMNeena M PatilEVP & Chief Legal Officer
Sale
55,600$191.56$10.7M58,818(D)

View →

Feb 26, 2026Mar 2 10:04 PMMary Elizabeth HendersonSVP, Technical Operations
Sale
5,343$194.49$1.0M28,728(D)

View →

Feb 27, 2026Feb 27 9:22 PMPATRICIA CARR
Proposed Sale
1,117$190.91$213.2K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Aug 27, 2026Aug 31 10:45 PMRobert IannoneEVP, Global Head of R&D & CMO
Option Exercise
57,500$137.120(D)

View →

May 28, 2026Jun 1 8:06 PMSamantha PearceEVP, Chief Commercial Officer
Option Exercise
6,907$109.450(D)

View →

May 28, 2026Jun 1 8:01 PMSeamus MulliganDirector
Option Exercise
3,415$138.080(D)

View →

May 22, 2026May 27 10:13 PMRick E WinninghamDirector
Option Exercise
3,415$138.080(D)

View →

Feb 27, 2026Mar 2 10:36 PMNorbert G RiedelDirector
Option Exercise
3,415$138.080(D)

View →

Feb 26, 2026Mar 2 10:06 PMNeena M PatilEVP & Chief Legal Officer
Option Exercise
51,000$137.120(D)

View →